192 related articles for article (PubMed ID: 33420762)
41. Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study.
Ording AG; Skjøth F; Andersen SD; Larsen TB
Thromb Haemost; 2022 Sep; 122(9):1524-1531. PubMed ID: 35688451
[TBL] [Abstract][Full Text] [Related]
42. Risk and complications of venous thromboembolism in dialysis patients.
Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
[TBL] [Abstract][Full Text] [Related]
43. Venous thromboembolism and risk of depression: a population-based cohort study.
Jørgensen H; Horváth-Puhó E; Laugesen K; Brækkan SK; Hansen JB; Sørensen HT
J Thromb Haemost; 2023 Apr; 21(4):953-962. PubMed ID: 36696217
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of risk factors for venous thromboembolism in Chinese women with epithelial ovarian cancer.
Wu X; Xue X; Tang J; Cheng X; Tian W; Jiang R; Zang R
Int J Gynecol Cancer; 2013 Jan; 23(1):65-72. PubMed ID: 23196757
[TBL] [Abstract][Full Text] [Related]
45. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
[TBL] [Abstract][Full Text] [Related]
46. Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
Desai RJ; Pawar A; Weinblatt ME; Kim SC
Arthritis Rheumatol; 2019 Jun; 71(6):892-900. PubMed ID: 30552833
[TBL] [Abstract][Full Text] [Related]
47. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
48. Feasibility and impact of screening for venous thromboembolism in treatment-naive lung cancer patients-Results of a prospective cohort study.
Muthu V; Narasimhan RL; Prasad KT; Ahluwalia J; Garg M; Behera D; Singh N
Indian J Cancer; 2022; 59(2):203-211. PubMed ID: 33753627
[TBL] [Abstract][Full Text] [Related]
49. Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database.
Penfound S; Lukey A; Hodgson J; Hopman WM; Hanley GE; Othman M
Gynecol Oncol; 2024 Jun; 185():116-120. PubMed ID: 38382168
[TBL] [Abstract][Full Text] [Related]
50. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
[TBL] [Abstract][Full Text] [Related]
51. Risk and Timing of Venous Thromboembolism After Surgery for Lung Cancer: A Nationwide Cohort Study.
Mørkved AL; Søgaard M; Skjøth F; Ording AG; Jensen M; Larsen TB; Jakobsen E; Højen AA; Noble S; Meldgaard P; Petersen RH; Christensen TD
Ann Thorac Surg; 2024 Feb; 117(2):289-296. PubMed ID: 37890818
[TBL] [Abstract][Full Text] [Related]
52. Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China.
Zhang W; Liu X; Cheng H; Yang Z; Zhang G
Medicine (Baltimore); 2018 Aug; 97(31):e11754. PubMed ID: 30075594
[TBL] [Abstract][Full Text] [Related]
53. High incidence of silent venous thromboembolism before treatment in ovarian cancer.
Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H
Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896
[TBL] [Abstract][Full Text] [Related]
54. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
Adiamah A; Ban L; West J; Humes DJ
Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
[TBL] [Abstract][Full Text] [Related]
55. Venous Thromboembolic Complications to Hysterectomy for Benign Disease: A Nationwide Cohort Study.
Kahr HS; Thorlacius-Ussing O; Christiansen OB; Skals RK; Torp-Pedersen C; Knudsen A
J Minim Invasive Gynecol; 2018; 25(4):715-723.e2. PubMed ID: 29198736
[TBL] [Abstract][Full Text] [Related]
56. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
57. Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
Liang S; Tang W; Ye S; Xiang L; Wu X; Yang H
Thromb Res; 2020 Jun; 190():129-134. PubMed ID: 32361343
[TBL] [Abstract][Full Text] [Related]
58. Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy.
Pant A; Liu D; Schink J; Lurain J
Int J Gynecol Cancer; 2014 Jul; 24(6):997-1002. PubMed ID: 24905613
[TBL] [Abstract][Full Text] [Related]
59. Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011.
Ording AG; Nielsen ME; Smith AB; Horváth-Puhó E; Sørensen HT
Urol Oncol; 2016 Jul; 34(7):292.e1-8. PubMed ID: 26971189
[TBL] [Abstract][Full Text] [Related]
60. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
Ho KM; Bham E; Pavey W
J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
